<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">PAR</journal-id><journal-title-group><journal-title>Proceedings of Anticancer Research</journal-title></journal-title-group><issn>2208-3545</issn><eissn>2208-3553</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/par.v7i6.5508</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Detection and Clinical Significance of Th17/Treg Cell-Related Factors in Patients with Gestational Diabetes Mellitus</title><url>https://artdesignp.com/journal/PAR/7/6/10.26689/par.v7i6.5508</url><author>QinJinjin,WangBei,CaoChenyuan,ZhaoYakun,WangJing,WuHongli</author><pub-date pub-type="publication-year"><year>2023</year></pub-date><volume>7</volume><issue>6</issue><history><date date-type="pub"><published-time>2023-11-22</published-time></date></history><abstract>Objective: To investigate the detection of Th17/Treg cell-related factors in patients with gestational diabetes mellitus (GDM) and its clinical significance. Methods: In this study, a retrospective cohort research method was used to collect the clinical data of 42 patients who were hospitalized in the Affiliated Hospital of Hebei University and received the diagnosis of GDM from January 2018 to December 2022, as well as 42 patients with normal pregnancies during the same period. The Th17/Treg expression levels and metabolism-related indexes in the peripheral blood of patients were detected by radioimmunoassay. Results: The relative expression of Th17 in the serum of patients in the GDM group was significantly higher than that of the control group, and the level of Treg was significantly lower than that of the control group (P &amp;lt; 0.05); the levels of FBG, FINS, 2hBG, TC, TG and HOMA-IR of the patients in the GDM group were significantly higher than that of the control group, and the level of HOMA-β was significantly lower than that of the control group (P &amp;lt; 0.05). Conclusion: The imbalance of the Th17/Treg cell ratio in patients with GDM may be related to their disease progression and prognosis, providing new ideas and strategies for the clinical treatment of GDM.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Yin X, Nie J, Nie X, et al., 2022, The Relationship Between Nuclear Factor-Erythrocyte-Related Factor 2 and Antioxidant Enzymes in the Placenta of Patients with Gestational Diabetes and the Metabolism of Umbilical Cord Endothelial Cells. Cellular and Molecular Biology, 68(12): 97–103.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Reza F, Golnoosh G, Sahar Y, et al., 2022, Circulating Levels of C1q/TNF-Related Protein 3 (CTRP3) and CTRP9 in Gestational Diabetes and Their Association with Insulin Resistance and Inflammatory Cytokines. Laboratory Medicine, 2022.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Li Q, Xu J, Fang H, et al., 2019, Changes of Serum IL-17, IL-1?, IL-10 Levels in Gestational Diabetes Mellitus Patients and Their Relationship with Insulin Resistance and Blood Lipids. Shandong Medicine, 59(4): 52–54.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Li D, Chen J, Cao X, et al., 2016, Changes in the Expression of Peripheral Blood Th17/Treg Cells and Related Cytokines in Diabetic Patients. Advances in Modern Biomedicine, 16(30): 5987–5989 + 5960.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Oztop N, Kusku-Kiraz Z, Dervisoglu E, et al., 2016, The Association of Glycemic Markers with Plasma Adipocytokine Levels in Women with Gestational Diabetes. Journal of Diabetes and Metabolism, 7(9): 1000699. https://doi.org/10.4172/2155-6156.1000699</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Kuzmicki M, Telejko B, Lipinska D, et al., 2014, The IL-6/IL-6R/sgp130 System and Th17 Associated Cytokines in Patients with Gestational Diabetes. Endokrynologia Polska, 65(3): 169–175.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Li Y, 2014, Study on the Expression Levels of Th1/Th2/Th17/Treg-Related Cytokines in Peripheral Blood of Diabetic Patients, Southern Medical University.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Kuzmicki M, Telejko B, Wawrusiewicz-Kurylonek N, et al., 2013, The Expression of Genes Involved in NF-?B Activation in Peripheral Blood Mononuclear Cells of Patients with Gestational Diabetes. European Journal of Endocrinology, 168(3): 419–427. https://doi.org/10.1530/EJE-12-0654</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>Song J, Liu N, Peng S, 2012, Detection and Clinical Significance of Th17/Treg Cell-Related Factors in Patients with Gestational Diabetes Mellitus. International Journal of Laboratory Medicine, 33(17): 2069–2070.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><p>Etaati Z, Moazzami Gordarzi R, Kalhori F, et al., 2012, T-Helper Cytokine Patterns and Related Antibodies in Patients with Gestational Diabetes Mellitus. Tehran University Medical Journal, 70(1): 15–20.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B11" content-type="article"><label>11</label><element-citation publication-type="journal"><p>He H, 2023, Medical Nutritional Measures for Patients with Gestational Diabetes Mellitus. Renren Health, 2023(15):44.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B12" content-type="article"><label>12</label><element-citation publication-type="journal"><p>Zhao Y, 2023, Effects of Health Promotion and Education on Compliance Behavior and Maternal and Infant Outcomes in Patients with Gestational Diabetes Mellitus. Famous Doctors, 2023(8): 189–191.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B13" content-type="article"><label>13</label><element-citation publication-type="journal"><p>Shen G, 2023, Nursing Care for Patients with Gestational Diabetes Mellitus Must be Emphasized. Health For All, 2023(5): 22.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B14" content-type="article"><label>14</label><element-citation publication-type="journal"><p>Guo S, 2022, Expression of Serum HbA1c and hs-CRP in Patients with Gestational Diabetes Mellitus and Its Relationship with the Occurrence of Neonatal Hypoglycemia. Henan Medical Research, 31(21): 3926–3929.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B15" content-type="article"><label>15</label><element-citation publication-type="journal"><p>Liu H, Liu F, 2022, Factors Associated with Abnormal Glucose Metabolism in Patients with Gestational Diabetes Mellitus in Second Pregnancy. Henan Medical Research, 31(18): 3357–3360.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
